TROY, Va., Dec. 2, 2025 /PRNewswire/ — As Americans approach the holiday season, they will eat some of the largest meals of the year. Nutrition experts say this is the perfect time to...

The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects RAHWAY, NJ, Oct. 20, 2025 – Merck (NYSE: MRK), known as MSD...

New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies Facility marks...

Innovation born in Charlottesville continues to advance patient care. Rivanna Medical has introduced the Accuro 3S, the first FDA-cleared system to provide real-time ultrasound guidance for spinal and epidural anesthesia....

Adovate is pleased to announce that it has successfully closed and oversubscribed its $6 million Convertible Note financing round. The strong interest in this round reflects continued support for our...

WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical...

The bright morning wind skips off Chesapeake Bay and whistles through the historic ironwork and brick frontages of Norfolk’s seafront. Hunter Walsh bowls into his office in Hampton Roads’ cluster...

TROY, Va. and SHAKOPEE, Minn., May 20, 2025 /PRNewswire/ — As consumer demand for clean-label, organic, and non-GMO products continues to surge, the pressure is mounting on ingredient suppliers to meet stringent certification standards...

Charlottesville, VA (June 3, 2025) — PS Fertility, the leading pioneer in the field of male fertility diagnostic testing, announced the successful completion of its $3.5 million Series A Preferred funding...

Charlottesville, VA – May 15, 2025 – Adovate, LLC (“Adovate” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics targeting the adenosine receptors, today announced its acceptance into Johnson &...